Bristol-Myers Squibb Co (BMY)
57.31
-0.27
(-0.47%)
USD |
NYSE |
Dec 24, 12:07
Bristol-Myers Squibb Cash from Investing (Quarterly): -219.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.591B |
| Cash from Financing (Quarterly) | -3.852B |
| Free Cash Flow | 13.80B |
| Free Cash Flow Per Share (Quarterly) | 2.593 |
| Free Cash Flow to Equity (Quarterly) | 7.904B |
| Free Cash Flow to Firm (Quarterly) | 5.633B |
| Free Cash Flow Yield | 11.87% |